为什么关注这家公司
Biofourmis is a significant player in the digital therapeutics and remote patient monitoring market, making it a crucial company to track for insights into the future of healthcare delivery. Its strategic partnerships with major pharmaceutical companies and health systems, along with its recent merger and acquisition activity, provide valuable signals for investors and strategists monitoring the digital health landscape.
战略主题与信号模式
战略主题
近期信号模式
信号历史
0 条该公司暂无追踪信号。
信号将随官方公告被索引后出现在此处。
我们正在追踪该公司的官方渠道，信号将在发现后自动入库。
同行与相关公司
全部公司Astellas Pharma
优势市场Major Japanese pharma company focused on urology, oncology, and transplantation
AstraZeneca
Anglo-Swedish pharma company with strong oncology and rare disease pipeline
BeiGene
优势市场China's largest global biotech company focused on innovative oncology medicines
Biocon
India's largest biopharmaceutical company and global biosimilars leader
CSL Limited
Global biotech leader in plasma-derived therapies and vaccines
Celltrion
优势市场South Korea's leading biosimilar manufacturer challenging global pharma giants